Mind Medicine Inc (NASDAQ: MNMD) flaunted slowness of -3.96% at $8.97, before settling in for the price of $9.34 at the close. Taking a more long-term approach, MNMD posted a 52-week range of $3.85-$12.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 2.29%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 41.32%. This publicly-traded company’s shares outstanding now amounts to $81.59 million, simultaneously with a float of $27.23 million. The organization now has a market capitalization sitting at $657.79 million. At the time of writing, stock’s 50-day Moving Average stood at $7.35, while the 200-day Moving Average is $7.30.
Mind Medicine Inc (MNMD) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Mind Medicine Inc industry. According to the most recent insider trade that took place on Dec 26 ’24, this organization’s Chief Executive Officer sold 19,106 shares at the rate of 7.43, making the entire transaction reach 141,958 in total value, affecting insider ownership by 526,666. Preceding that transaction, on Dec 26 ’24, Company’s Chief Accounting Officer sold 2,273 for 7.43, making the whole transaction’s value amount to 16,888. This particular insider is now the holder of 97,270 in total.
Mind Medicine Inc (MNMD) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
Mind Medicine Inc’s EPS increase for this current 12-month fiscal period is 41.32% and is forecasted to reach -1.49 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.93% through the next 5 years, which can be compared against the 2.29% growth it accomplished over the previous five years trading on the market.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Let’s observe the current performance indicators for Mind Medicine Inc (MNMD). It’s Quick Ratio in the last reported quarter now stands at 9.00. The Stock has managed to achieve an average true range (ATR) of 0.73.
In the same vein, MNMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.09, a figure that is expected to reach -0.29 in the next quarter, and analysts are predicting that it will be -1.49 at the market close of one year from today.
Technical Analysis of Mind Medicine Inc (MNMD)
Now, what If we examine the latest scores posted by [Mind Medicine Inc, MNMD]. During the last 5-days, its volume was better the volume of 2.02 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 79.41% While, its Average True Range was 0.80.
Raw Stochastic average of Mind Medicine Inc (MNMD) in the period of the previous 100 days is set at 76.20%, which indicates a major rise in contrast to 67.37% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 93.28% that was higher than 82.04% volatility it exhibited in the past 100-days period.
